243 related articles for article (PubMed ID: 29631466)
1. Radiofrequency ablation (RFA)-induced systemic tumor growth can be reduced by suppression of resultant heat shock proteins.
Ahmed M; Kumar G; Gourevitch S; Levchenko T; Galun E; Torchilin V; Goldberg SN
Int J Hyperthermia; 2018 Nov; 34(7):934-942. PubMed ID: 29631466
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Thermal Ablation: Effect of Device and Heating Parameters on Local Tissue Reactions and Distant Tumor Growth.
Velez E; Goldberg SN; Kumar G; Wang Y; Gourevitch S; Sosna J; Moon T; Brace CL; Ahmed M
Radiology; 2016 Dec; 281(3):782-792. PubMed ID: 27409564
[TBL] [Abstract][Full Text] [Related]
3. Effect of thermal dose on heat shock protein expression after radio-frequency ablation with and without adjuvant nanoparticle chemotherapies.
Moussa M; Goldberg SN; Kumar G; Levchenko T; Torchilin V; Ahmed M
Int J Hyperthermia; 2016 Dec; 32(8):829-841. PubMed ID: 27600101
[TBL] [Abstract][Full Text] [Related]
4. Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy.
Ahmed M; Kumar G; Navarro G; Wang Y; Gourevitch S; Moussa MH; Rozenblum N; Levchenko T; Galun E; Torchilin VP; Goldberg SN
PLoS One; 2015; 10(7):e0128910. PubMed ID: 26154425
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Radiofrequency Ablation-induced Stimulation of Distant Tumor Growth Is Suppressed by c-Met Inhibition.
Ahmed M; Kumar G; Moussa M; Wang Y; Rozenblum N; Galun E; Goldberg SN
Radiology; 2016 Apr; 279(1):103-17. PubMed ID: 26418615
[TBL] [Abstract][Full Text] [Related]
6. Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation.
Kumar G; Goldberg SN; Gourevitch S; Levchenko T; Torchilin V; Galun E; Ahmed M
Radiology; 2018 Feb; 286(2):524-536. PubMed ID: 28880787
[TBL] [Abstract][Full Text] [Related]
7. Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition.
Kumar G; Goldberg SN; Wang Y; Velez E; Gourevitch S; Galun E; Ahmed M
Eur Radiol; 2017 Mar; 27(3):1238-1247. PubMed ID: 27287478
[TBL] [Abstract][Full Text] [Related]
8. Combination radiofrequency (RF) ablation and IV liposomal heat shock protein suppression: reduced tumor growth and increased animal endpoint survival in a small animal tumor model.
Yang W; Ahmed M; Tasawwar B; Levchenko T; Sawant RR; Torchilin V; Goldberg SN
J Control Release; 2012 Jun; 160(2):239-44. PubMed ID: 22230341
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation-induced upregulation of hypoxia-inducible factor-1α can be suppressed with adjuvant bortezomib or liposomal chemotherapy.
Moussa M; Goldberg SN; Kumar G; Sawant RR; Levchenko T; Torchilin V; Ahmed M
J Vasc Interv Radiol; 2014 Dec; 25(12):1972-82. PubMed ID: 25439675
[TBL] [Abstract][Full Text] [Related]
10. Nanodrug-enhanced radiofrequency tumor ablation: effect of micellar or liposomal carrier on drug delivery and treatment efficacy.
Moussa M; Goldberg SN; Kumar G; Sawant RR; Levchenko T; Torchilin VP; Ahmed M
PLoS One; 2014; 9(8):e102727. PubMed ID: 25133740
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model.
Yang W; Ahmed M; Tasawwar B; Levchenko T; Sawant RR; Collins M; Signoretti S; Torchilin V; Goldberg SN
Int J Hyperthermia; 2011; 27(6):527-38. PubMed ID: 21846189
[TBL] [Abstract][Full Text] [Related]
12. Incomplete thermal ablation of tumors promotes increased tumorigenesis.
Markezana A; Goldberg SN; Kumar G; Zorde-Khvalevsky E; Gourevtich S; Rozenblum N; Galun E; Ahmed M
Int J Hyperthermia; 2021; 38(1):263-272. PubMed ID: 33612046
[TBL] [Abstract][Full Text] [Related]
13. Can two-step ablation combined with chemotherapeutic liposomes achieve better outcome than traditional RF ablation? A solid tumor animal study.
Zhao K; Wu H; Yang W; Cheng Y; Wang S; Jiang AN; Yan K; Goldberg SN
Nanoscale; 2022 May; 14(17):6312-6322. PubMed ID: 35393985
[No Abstract] [Full Text] [Related]
14. Myofibroblasts: A key promoter of tumorigenesis following radiofrequency tumor ablation.
Moussa M; Mwin D; Liao H; Atac MF; Markezana A; Galun E; Goldberg SN; Ahmed M
PLoS One; 2022; 17(7):e0266522. PubMed ID: 35857766
[TBL] [Abstract][Full Text] [Related]
15. Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model?
Yang W; Ahmed M; Elian M; Hady el-SA; Levchenko TS; Sawant RR; Signoretti S; Collins M; Torchilin VP; Goldberg SN
Radiology; 2010 Dec; 257(3):685-96. PubMed ID: 20858851
[TBL] [Abstract][Full Text] [Related]
16. RF ablation with adjuvant therapy: comparison of external beam radiation and liposomal doxorubicin on ablation efficacy in an animal tumor model.
Solazzo S; Mertyna P; Peddi H; Ahmed M; Horkan C; Goldberg SN
Int J Hyperthermia; 2008 Nov; 24(7):560-7. PubMed ID: 18608584
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein inhibitor, quercetin, as a novel adjuvant agent to improve radiofrequency ablation-induced tumor destruction and its molecular mechanism.
Yang W; Cui M; Lee J; Gong W; Wang S; Fu J; Wu G; Yan K
Chin J Cancer Res; 2016 Feb; 28(1):19-28. PubMed ID: 27041924
[TBL] [Abstract][Full Text] [Related]
18. Thermal Ablation Induces Transitory Metastatic Growth by Means of the STAT3/c-Met Molecular Pathway in an Intrahepatic Colorectal Cancer Mouse Model.
Liao H; Ahmed M; Markezana A; Zeng G; Stechele M; Galun E; Goldberg SN
Radiology; 2020 Feb; 294(2):464-472. PubMed ID: 31845846
[TBL] [Abstract][Full Text] [Related]
19. Heat shock protein 70 is induced in mouse human colon tumor xenografts after sublethal radiofrequency ablation.
Yang WL; Nair DG; Makizumi R; Gallos G; Ye X; Sharma RR; Ravikumar TS
Ann Surg Oncol; 2004 Apr; 11(4):399-406. PubMed ID: 15070600
[TBL] [Abstract][Full Text] [Related]
20. Combined thermal ablation and liposomal granulocyte-macrophage colony stimulation factor increases immune cell trafficking in a small animal tumor model.
Moussa M; Chowdhury MR; Mwin D; Fatih M; Selveraj G; Abdelmonem A; Farghaly M; Dou Q; Filipczak N; Levchenko T; Torchilin VP; Boussiotis V; Goldberg SN; Ahmed M
PLoS One; 2023; 18(10):e0293141. PubMed ID: 37883367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
